{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:05:45Z","timestamp":1784761545210,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52968-9","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:47:26Z","timestamp":1779277646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design, synthesis, and anticancer activity of phenoxyacetohydrazide derivatives in burkitt lymphoma"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1086-7292","authenticated-orcid":false,"given":"Yasser Hussein Issa","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4532-9128","authenticated-orcid":false,"given":"Saad","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hibah Ali","family":"Almasmoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-5622","authenticated-orcid":false,"given":"Ahmed Hassen","family":"Shntaif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Suhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodour S.","family":"Rajab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadeq K.","family":"Alhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariah N.","family":"Hafiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Senan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"3","key":"52968_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74 (3), 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2022).","journal-title":"Cancer J. Clin."},{"key":"52968_CR2","doi-asserted-by":"publisher","unstructured":"Halcu, G. et al. From Biopsy to Diagnosis: Navigating Aggressive B-Cell Lymphomas in Practice. Med. (Kaunas). 61 (5). https:\/\/doi.org\/10.3390\/medicina61050842 (2025).","DOI":"10.3390\/medicina61050842"},{"issue":"4","key":"52968_CR3","doi-asserted-by":"publisher","first-page":"e240925","DOI":"10.1136\/bcr-2020-240925","volume":"14","author":"A Al Sbihi","year":"2021","unstructured":"Al Sbihi, A., Manasrah, N., Sano, D. & Lonardo, S. Early-stage Burkitt lymphoma remained in remission 7 years from diagnosis after only one cycle of chemoimmunotherapy. BMJ Case Rep. 14 (4), e240925. https:\/\/doi.org\/10.1136\/bcr-2020-240925 (2021).","journal-title":"BMJ Case Rep."},{"key":"52968_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/hemato3030030","volume":"3.3","author":"M MBULAITEYE, Sam","year":"2022","unstructured":"MBULAITEYE, Sam, M. & Susan, D. E. V. E. S. A. Burkitt lymphoma incidence in five continents. Hemato 3.3, 434\u2013453 (2022).","journal-title":"Hemato"},{"issue":"12","key":"52968_CR5","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1080\/10428194.2022.2100368","volume":"63","author":"ONS CHANG","year":"2022","unstructured":"CHANG, O. N. S. & Abraham Treatment of lymphoma with rituximab and chemotherapy during pregnancy. Leuk. Lymphoma. 63 (12), 2897\u20132904 (2022).","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"52968_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12935-025-03655-8","volume":"25","author":"R Panahizadeh","year":"2025","unstructured":"Panahizadeh, R. et al. A literature review of recent advances in gastric cancer treatment: exploring the cross-talk between targeted therapies. Cancer Cell Int. 25 (1), 23. https:\/\/doi.org\/10.1186\/s12935-025-03655-8 (2025).","journal-title":"Cancer Cell Int."},{"issue":"1","key":"52968_CR7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","volume":"16","author":"A Zafar","year":"2025","unstructured":"Zafar, A., Khatoon, S., Khan, M. J., Abu, J. & Naeem, A. Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discover Oncol. 16 (1), 607. https:\/\/doi.org\/10.1007\/s12672-025-02198-8 (2025).","journal-title":"Discover Oncol."},{"issue":"9","key":"52968_CR8","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3390\/pharmaceutics16091237","volume":"16","author":"D Ovcharenko","year":"2024","unstructured":"Ovcharenko, D., Mukhin, D. & Ovcharenko, G. Alternative Cancer Therapeutics: Unpatentable Compounds and Their Potential in Oncology. Pharmaceutics 16 (9), 1237 (2024).","journal-title":"Pharmaceutics"},{"issue":"17","key":"52968_CR9","doi-asserted-by":"publisher","first-page":"9389","DOI":"10.3390\/ijms22179389","volume":"22","author":"\u0141 Popio\u0142ek","year":"2021","unstructured":"Popio\u0142ek, \u0141. Updated Information on Antimicrobial Activity of Hydrazide\u2013Hydrazones. Int. J. Mol. Sci. 22 (17), 9389 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"52968_CR10","doi-asserted-by":"publisher","unstructured":"Zlatanova-Tenisheva, H. & Vladimirova, S. Pharmacological Evaluation of Novel Hydrazide and Hydrazone Derivatives: Anti-Inflammatory and Analgesic Potential in Preclinical Models. Molecules 30 (7). https:\/\/doi.org\/10.3390\/molecules30071472 (2025).","DOI":"10.3390\/molecules30071472"},{"issue":"7","key":"52968_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cpan.2025.08.001","volume":"21","author":"M El Bouamri","year":"2025","unstructured":"El Bouamri, M., Yafout, M., Bennis, S., Ait Haj Said, A. & Benmoussa, A. Design, synthesis, and therapeutic potential of pyridazinone-based molecules: An updated comprehensive review. Curr. Pharm. Anal. 21 (7), 349\u2013362. https:\/\/doi.org\/10.1016\/j.cpan.2025.08.001 (2025).","journal-title":"Curr. Pharm. Anal."},{"issue":"14","key":"52968_CR12","doi-asserted-by":"publisher","first-page":"14171","DOI":"10.1021\/acs.jmedchem.5c01677","volume":"68","author":"A Raucci","year":"2025","unstructured":"Raucci, A., Zwergel, C., Valente, S. & Mai, A. Advancements in Hydrazide-Based HDAC Inhibitors: A Review of Recent Developments and Therapeutic Potential. J. Med. Chem. 68 (14), 14171\u201314194. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01677 (2025).","journal-title":"J. Med. Chem."},{"issue":"5","key":"52968_CR13","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.3390\/ijms22052742","volume":"22","author":"M Horchani","year":"2021","unstructured":"Horchani, M. et al. Molecular Docking and Biophysical Studies for Antiproliferative Assessment of Synthetic Pyrazolo-Pyrimidinones Tethered with Hydrazide-Hydrazones. Int. J. Mol. Sci. 22 (5), 2742 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"52968_CR14","doi-asserted-by":"publisher","first-page":"29289","DOI":"10.1038\/s41598-024-76823-x","volume":"14","author":"YHI Mohammed","year":"2024","unstructured":"Mohammed, Y. H. I. et al. Synthesis and multifaceted evaluation of novel AgCZ nanocomposite for targeted anti-angiogenic cancer therapy. Sci. Rep. 14 (1), 29289. https:\/\/doi.org\/10.1038\/s41598-024-76823-x (2024).","journal-title":"Sci. Rep."},{"issue":"8","key":"52968_CR15","doi-asserted-by":"publisher","first-page":"7854","DOI":"10.1021\/acs.jmedchem.4c02228","volume":"68","author":"M Maciag","year":"2025","unstructured":"Maciag, M. & Karamyan, V. T. The missing enzymes: a call to update pharmacological profiling practices for better drug safety assessment. J. Med. Chem. 68 (8), 7854\u20137865 (2025).","journal-title":"J. Med. Chem."},{"issue":"10","key":"52968_CR16","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1021\/acs.jchemed.3c00307","volume":"100","author":"AG FIKES","year":"2023","unstructured":"FIKES, A. G. & SROUGI, M. C. Design and Implementation of an Accessible and Open-Sourced In Silico Drug Screening Activity for Cancer Drug Discovery. J. Chem. Educ. 100 (10), 4125\u20134130 (2023).","journal-title":"J. Chem. Educ."},{"issue":"5","key":"52968_CR17","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1021\/acs.jafc.2c07575","volume":"71","author":"HX Li","year":"2023","unstructured":"Li, H. X. et al. Structural simplification of cryptolepine to obtain novel antifungal quinoline derivatives against phytopathogenic fungi. J. Agric. Food Chem. 71 (5), 2301\u20132312 (2023).","journal-title":"J. Agric. Food Chem."},{"issue":"13","key":"52968_CR18","doi-asserted-by":"publisher","first-page":"6848","DOI":"10.3390\/ijms25136848","volume":"25","author":"H-J Kao","year":"2024","unstructured":"Kao, H-J. et al. Integrating In Silico and In Vitro Approaches to Identify Natural Peptides with Selective Cytotoxicity against Cancer Cells. Int. J. Mol. Sci. 25 (13), 6848 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"52968_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/pai.0000000000000967","volume":"30","author":"B Thirunavukkarasu","year":"2022","unstructured":"Thirunavukkarasu, B. et al. Screening Strategy for Detecting Double-Hit Lymphoma in a Resource-Limited Setting. Appl. Immunohistochem. Mol. Morphology. 30 (1), 49\u201355. https:\/\/doi.org\/10.1097\/pai.0000000000000967 (2022).","journal-title":"Appl. Immunohistochem. Mol. Morphology"},{"key":"52968_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-0716-3056-3_8","volume-title":"Cancer Cell Culture: Methods and Protocols","author":"A Chary","year":"2023","unstructured":"Chary, A. Culturing Human Lung Adenocarcinoma Cells in a Serum-Free Environment. In Cancer Cell Culture: Methods and Protocols (eds Movia, D. & Prina-Mello, A.) 165\u2013172 (Springer US, 2023)."},{"issue":"13","key":"52968_CR21","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.3390\/ijms22136692","volume":"22","author":"A Czylkowska","year":"2021","unstructured":"Czylkowska, A. et al. Cytotoxic Activity against A549 Human Lung Cancer Cells and ADMET Analysis of New Pyrazole Derivatives. Int. J. Mol. Sci. 22 (13), 6692 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"52968_CR22","doi-asserted-by":"crossref","unstructured":"Harlendea, N. J. & Harlendo, K. Ki-67 as a marker to differentiate Burkitt lymphoma and diffuse large B-cell lymphoma: A literature review. Cureus, ; 16(10) e72190. (2024).","DOI":"10.7759\/cureus.72190"},{"key":"52968_CR23","doi-asserted-by":"crossref","unstructured":"Choudhary, S. et al. Alternative models for evaluation of ocular toxicological effects of environmental chemicals and pharmaceuticals: a review. Cutan. Ocul. Toxicol.,  45(1), 1\u201323. (2026).","DOI":"10.1080\/15569527.2025.2607700"},{"issue":"9","key":"52968_CR24","doi-asserted-by":"publisher","first-page":"e0330731","DOI":"10.1371\/journal.pone.0330731","volume":"20","author":"YHI Mohammed","year":"2025","unstructured":"Mohammed, Y. H. I. et al. Synthesis of novel phenoxyacetohydrazide compounds and evaluation therapeutic potential exhibit as anti-inflammatory and anti-angiogenic. PLOS ONE. 20 (9), e0330731. https:\/\/doi.org\/10.1371\/journal.pone.0330731 (2025).","journal-title":"PLOS ONE"},{"issue":"3","key":"52968_CR25","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/molecules28031117","volume":"28","author":"SH Deshpande","year":"2023","unstructured":"Deshpande, S. H. et al. Silico Study on the Interactions, Molecular Docking, Dynamics and Simulation of Potential Compounds from Withania somnifera (L.) Dunal Root against Cancer by Targeting KAT6A. Molecules 28 (3), 1117 (2023).","journal-title":"Molecules"},{"issue":"2","key":"52968_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.22037\/ijpr.2019.15297.13037","volume":"19","author":"H Kalhor","year":"2020","unstructured":"Kalhor, H., Rahimi, H., Akbari Eidgahi, M. R. & Teimoori-Toolabi, L. Novel Small Molecules against Two Binding Sites of Wnt2 Protein as potential Drug Candidates for Colorectal Cancer: A Structure Based Virtual Screening Approach. Iran. J. Pharm. Res. 19 (2), 160\u2013174. https:\/\/doi.org\/10.22037\/ijpr.2019.15297.13037 (2020).","journal-title":"Iran. J. Pharm. Res."},{"issue":"3","key":"52968_CR27","doi-asserted-by":"publisher","first-page":"979","DOI":"10.4251\/wjgo.v16.i3.979","volume":"16","author":"YM Wang","year":"2024","unstructured":"Wang, Y. M. et al. Effects of Helicobacter pylori and Moluodan on the Wnt\/\u03b2-catenin signaling pathway in mice with precancerous gastric cancer lesions. World J. Gastrointest. Oncol. 16 (3), 979\u2013990. https:\/\/doi.org\/10.4251\/wjgo.v16.i3.979 (2024).","journal-title":"World J. Gastrointest. Oncol."},{"issue":"1","key":"52968_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1158\/1535-7163.Mct-22-0642","volume":"23","author":"W Li","year":"2024","unstructured":"Li, W. et al. Bruton\u2019s Tyrosine Kinase Inhibitors with Distinct Binding Modes Reveal Differential Functional Impact on B-Cell Receptor Signaling. Mol. Cancer Ther. 23 (1), 35\u201346. https:\/\/doi.org\/10.1158\/1535-7163.Mct-22-0642 (2024).","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"52968_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s43440-021-00345-w","volume":"74","author":"SA Banumathi","year":"2022","unstructured":"Banumathi, S. A. et al. Antiproliferative pharmacophore azo-hydrazone analogue BT-1F exerts death signalling pathway targeting STAT3 in solid tumour. Pharmacol. Rep. 74 (2), 353\u2013365. https:\/\/doi.org\/10.1007\/s43440-021-00345-w (2022). Epub 2022 Jan 10. PMID: 35001321.","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"52968_CR30","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00044-024-03224-0","volume":"33","author":"F Plescia","year":"2024","unstructured":"Plescia, F. et al. A very promising antibiofilm activity against Candida albicans from an in vitro screening for antimicrobial, antibiofilm and antiproliferative activity of new synthesized 4-cinnamamido-and 2-phenoxyacedamido-1H-pyrazol-5-yl) benzamides. Med. Chem. Res. 33 (6), 903\u2013917 (2024).","journal-title":"Med. Chem. Res."},{"key":"52968_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45010007","author":"LR Venkataravanappa","year":"2023","unstructured":"Venkataravanappa, L. R. et al. Design, Synthesis, Characterization, and Analysis of Antimicrobial Property of Novel Benzophenone Fused Azetidinone Derivatives through In Vitro and In Silico Approach. Curr. Issues. Mol. Biol. https:\/\/doi.org\/10.3390\/cimb45010007 (2023).","journal-title":"Curr. Issues. Mol. Biol."},{"key":"52968_CR32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bioorg.2019.03.038","volume":"87","author":"KP Rakesh","year":"2019","unstructured":"Rakesh, K. P., Kumara, H. K., Manukumar, H. M. & Channe Gowda, D. Anticancer and DNA binding studies of potential amino acids based quinazolinone analogs: Synthesis, SAR and molecular docking. Bioorg. Chem. 87, 252\u2013264. https:\/\/doi.org\/10.1016\/j.bioorg.2019.03.038 (2019).","journal-title":"Bioorg. Chem."},{"issue":"2","key":"52968_CR33","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.15419\/bmrat.v12i2.960","volume":"12","author":"AI Hassan","year":"2025","unstructured":"Hassan, A. I., Bondouk, I. I., Abdelrahman, M. T. & Saleh, H. M. Cytotoxicity and antiproliferative activity of Arctium lappa extract on an in vitro model of human colorectal cancer. Biomedical Res. Therapy. 12 (2), 7153\u20137167 (2025).","journal-title":"Biomedical Res. Therapy"},{"issue":"7","key":"52968_CR34","first-page":"1665","volume":"21","author":"YX Zhang","year":"2017","unstructured":"Zhang, Y. X., Yu, P. F., Gao, Z. M., Yuan, J. & Zhang, Z. Caffeic acid n-butyl ester-triggered necrosis-like cell death in lung cancer cell line A549 is prompted by ROS mediated alterations in mitochondrial membrane potential. Eur. Rev. Med. Pharmacol. Sci. 21 (7), 1665\u20131671 (2017).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"52968_CR35","doi-asserted-by":"publisher","first-page":"143635","DOI":"10.1016\/j.foodchem.2025.143635","volume":"477","author":"S Huang","year":"2025","unstructured":"Huang, S. et al. Effects of chemical modifications on allergenicity and functional properties of silkworm pupae proteins. Food Chem. 477, 143635 (2025).","journal-title":"Food Chem."},{"issue":"22","key":"52968_CR36","doi-asserted-by":"publisher","first-page":"11029","DOI":"10.3390\/ijms262211029","volume":"26","author":"N Al-Damook","year":"2025","unstructured":"Al-Damook, N. et al. Targeting Cancer Through Thymoquinone: From Molecular Mechanisms to Clinical Prospects. Int. J. Mol. Sci. 26 (22), 11029 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"52968_CR37","doi-asserted-by":"publisher","unstructured":"Ng, J. P. L. et al. Biological Evaluation in Resistant Cancer Cells and Study of Mechanism of Action of Arylvinyl-1,2,4-Trioxanes. Pharmaceuticals 2022 https:\/\/doi.org\/10.3390\/ph15030360","DOI":"10.3390\/ph15030360"},{"issue":"1","key":"52968_CR38","doi-asserted-by":"publisher","first-page":"22824","DOI":"10.1038\/s41598-023-44662-x","volume":"13","author":"YHI Mohammed","year":"2023","unstructured":"Mohammed, Y. H. I. et al. Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies. Sci. Rep. 13 (1), 22824. https:\/\/doi.org\/10.1038\/s41598-023-44662-x (2023).","journal-title":"Sci. Rep."},{"key":"52968_CR39","first-page":"e66395","volume":"217","author":"B Ohm","year":"2025","unstructured":"Ohm, B. et al. Picrosirius red staining for semiquantitative histopathologic evaluation of collagen deposition in murine models of chronic lung allograft rejection. JoVE (Journal Visualized Experiments). 217, e66395 (2025).","journal-title":"JoVE (Journal Visualized Experiments)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52968-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52968-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52968-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:48:45Z","timestamp":1784760525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52968-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52968"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52968-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23011"}}